相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Noradrenergic System in Down Syndrome and Alzheimer's Disease A Target for Therapy
Cristy Phillips et al.
CURRENT ALZHEIMER RESEARCH (2016)
Critical role of somatostatin receptor 2 in the vulnerability of the central noradrenergic system: new aspects on Alzheimer's disease
Csaba Adori et al.
ACTA NEUROPATHOLOGICA (2015)
Norepinephrine induces the expression of interleukin-6 via β-adrenoreceptor-NAD(P)H oxidase system -NF-κB dependent signal pathway in U937 macrophages
Ming Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Lesion of the locus coeruleus aggravates dopaminergic neuron degeneration by modulating microglial function in mouse models of Parkinson's disease
Ning Yao et al.
BRAIN RESEARCH (2015)
No Significant Effect of 7,8-Dihydroxyflavone on APP Processing and Alzheimer-Associated Phenotypes
Weitao Zhou et al.
CURRENT ALZHEIMER RESEARCH (2015)
Organization of the Locus Coeruleus-Norepinephrine System
Lindsay A. Schwarz et al.
CURRENT BIOLOGY (2015)
Droxidopa: A Review of Its Use in Symptomatic Neurogenic Orthostatic Hypotension
Gillian M. Keating
DRUGS (2015)
Neurotransmitter Systems in a Mild Blast Traumatic Brain Injury Model: Catecholamines and Serotonin
Lizan Kawa et al.
JOURNAL OF NEUROTRAUMA (2015)
Anti-inflammatory effects of noradrenaline on LPS-treated microglial cells: Suppression of NFκB nuclear translocation and subsequent STAT1 phosphorylation
Yurika Ishii et al.
NEUROCHEMISTRY INTERNATIONAL (2015)
7,8-Dihydroxyflavone as a pro-neurotrophic treatment for neurodevelopmental disorders
X. Du et al.
NEUROCHEMISTRY INTERNATIONAL (2015)
ALLOPREGNANOLONE ENHANCES THE NEUROGENESIS OF MIDBRAIN DOPAMINERGIC NEURONS IN APPSWE/PSEN1 MICE
P. Zhang et al.
NEUROSCIENCE (2015)
Catecholamine-based treatment in AD patients: expectations and delusions
Alessandro Stefani et al.
FRONTIERS IN AGING NEUROSCIENCE (2015)
The involvement of BDNF, NGF and GDNF in aging and Alzheimer's disease
Josiane Budni et al.
AGING AND DISEASE (2015)
Noradrenergic dysfunction in Alzheimer's disease
Mary Gannon et al.
FRONTIERS IN NEUROSCIENCE (2015)
Adrenergic regulation of innate immunity: a review
Angela Scanzano et al.
FRONTIERS IN PHARMACOLOGY (2015)
Degeneration in arousal neurons in chronic sleep disruption modeling sleep apnea
Yan Zhu et al.
FRONTIERS IN NEUROLOGY (2015)
Cataplexy and Sleep Disorders in Niemann-Pick Type C Disease
Sona Nevsimalova et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2015)
Treatment of Mood Disorders in Multiple Sclerosis
Luis Pintor Perez et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2015)
DSP4, a Selective Neurotoxin for the Locus Coeruleus Noradrenergic System. A Review of Its Mode of Action
Svante B. Ross et al.
NEUROTOXICITY RESEARCH (2015)
Projection specificity in heterogeneous locus coeruleus cell populations: implications for learning and memory
Akira Uematsu et al.
LEARNING & MEMORY (2015)
Sleep, circadian rhythms, and the pathogenesis of Alzheimer Disease
Erik S. Musiek et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2015)
Formoterol, a Long-Acting β2 Adrenergic Agonist, Improves Cognitive Function and Promotes Dendritic Complexity in a Mouse Model of Down Syndrome
Van Dang et al.
BIOLOGICAL PSYCHIATRY (2014)
Noradrenergic Regulation of Glial Activation: Molecular Mechanisms and Therapeutic Implications
David Braun et al.
CURRENT NEUROPHARMACOLOGY (2014)
Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer’s Disease: A Translational Overview
P.R.A. Heckman et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease
Eunju Shin et al.
EXPERIMENTAL NEUROLOGY (2014)
Monoamine oxidase and α-synuclein as targets in Parkinson's disease therapy
Cristian Follmer
EXPERT REVIEW OF NEUROTHERAPEUTICS (2014)
Loss of locus coeruleus noradrenergic neurons alters the inflammatory response to LPS in substantia nigra but does not affect nigral cell loss
Mahmoud M. Iravani et al.
JOURNAL OF NEURAL TRANSMISSION (2014)
The blood-brain barrier-permeable catechol-O-methyltransferase inhibitor dinitrocatechol suppresses experimental autoimmune encephalomyelitis
Paul E. Polak et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Ear2 Deletion Causes Early Memory and Learning Deficits in APP/PS1 Mice
Markus P. Kummer et al.
JOURNAL OF NEUROSCIENCE (2014)
Norepinephrine activates NF-κB transcription factor in cultured rat pineal gland
Darine Villela et al.
LIFE SCIENCES (2014)
Norepinephrine Deficiency in Parkinson's Disease: The Case for Noradrenergic Enhancement
Alberto J. Espay et al.
MOVEMENT DISORDERS (2014)
Norepinephrine provides short-term neuroprotection against Aβ1-42 by reducing oxidative stress independent of Nrf2 activation
Kyoung A. Jhang et al.
NEUROBIOLOGY OF AGING (2014)
Age and duration of inflammatory environment differentially affect the neuroimmune response and catecholaminergic neurons in the midbrain and brainstem
Isabelle Bardou et al.
NEUROBIOLOGY OF AGING (2014)
Uptake of environmental toxicants by the locus ceruleus: A potential trigger for neurodegenerative, demyelinating and psychiatric disorders
Roger Pamphlett
MEDICAL HYPOTHESES (2014)
Noradrenaline acting on astrocytic β2-adrenoceptars induces neurite outgrowth in primary cortical neurons
Jennifer S. Day et al.
NEUROPHARMACOLOGY (2014)
7,8-Dihydroxyflavone Prevents Synaptic Loss and Memory Deficits in a Mouse Model of Alzheimer's Disease
Zhentao Zhang et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Vagus nerve stimulation...25 years later! What do we know about the effects on cognition?
Kristl Vonck et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2014)
Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: Focus on modulation of CNS monoamine neurotransmitter release
John P. M. Finberg
PHARMACOLOGY & THERAPEUTICS (2014)
Comparison of Sertraline, Venlafaxine and Desipramine Effects on Depression, Cognition and the Daily Living Activities in Alzheimer Patients
N. Mokhber et al.
PHARMACOPSYCHIATRY (2014)
alpha(2A) adrenergic receptor promotes amyloidogenesis through disrupting APP-SorLA interaction
Yunjia Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Revisiting the roles of progesterone and allopregnanolone in the nervous system: Resurgence of the progesterone receptors
M. Schumacher et al.
PROGRESS IN NEUROBIOLOGY (2014)
Psychiatric symptoms of noradrenergic dysfunction: A pathophysiological view
Ken-ichi Yamamoto et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2014)
Effect of vinpocetine (cognitol) on cognitive performances of a Nigerian population
A. O. Ogunrin
ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH (2014)
Brain-Derived Neurotrophic Factor in Neuroimmunology: Lessons Learned from Multiple Sclerosis Patients and Experimental Autoimmune Encephalomyelitis Models
Fred Luehder et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2013)
The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE)
Curtis A. Benson et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Selective Loss of Noradrenaline Exacerbates Early Cognitive Dysfunction and Synaptic Deficits in APP/PS1 Mice
Thea Hammerschmidt et al.
BIOLOGICAL PSYCHIATRY (2013)
Pathophysiological background and clinical characteristics of sleep disorders in multiple sclerosis
Barbara Barun
CLINICAL NEUROLOGY AND NEUROSURGERY (2013)
Duloxetine Is Effective in Treating Depression in Multiple Sclerosis Patients: An Open-Label Multicenter Study
Claudio Solaro et al.
CLINICAL NEUROPHARMACOLOGY (2013)
Altered locus coeruleus-norepinephrine function following single prolonged stress
Sophie A. George et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2013)
Dual effects of noradrenaline on astroglial production of chemokines and pro-inflammatory mediators
Ara E. Hinojosa et al.
JOURNAL OF NEUROINFLAMMATION (2013)
The Impact of Pathogenic Mitochondrial DNA Mutations on Substantia Nigra Neurons
Amy Reeve et al.
JOURNAL OF NEUROSCIENCE (2013)
Catechol-O-Methyltransferase Val158Met Polymorphism (rs4680) Is Associated With Pain in Multiple Sclerosis
Cesar Fernandez-de-las-Penas et al.
JOURNAL OF PAIN (2013)
Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder
Michelle J. Chandley et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2013)
Functional neuroanatomy of the central noradrenergic system
Elemer Szabadi
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Prazosin, an α1-adrenoceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer's disease
Loukia Katsouri et al.
NEUROBIOLOGY OF AGING (2013)
Selegiline Reverses Aβ25-35-Induced Cognitive Deficit in Male Mice
Andreia M. Pazini et al.
NEUROCHEMICAL RESEARCH (2013)
Ascending monoaminergic systems alterations in Alzheimer's disease. Translating basic science into clinical care
Ludwig Trillo et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
Sleep Drives Metabolite Clearance from the Adult Brain
Lulu Xie et al.
SCIENCE (2013)
被撤回的出版物: Association of Posttraumatic Stress Disorder With Reduced In Vivo Norepinephrine Transporter Availability in the Locus Coeruleus (Retracted article. See vol. 77, pg. 454, 2020)
Robert H. Pietrzak et al.
JAMA PSYCHIATRY (2013)
The relationship between subcortical tau pathology and Alzheimer's disease
Johannes Attems et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Immunohistochemical evidence for impaired nitric oxide signaling of the locus coeruleus in bipolar disorder
Hendrik Bielau et al.
BRAIN RESEARCH (2012)
Catechol-O-Methyltransferase and Alzheimer's Disease: A Review of Biological and Genetic Findings
Alessandro Serretti et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2012)
Allopregnanolone Increases the Number of Dopaminergic Neurons in Substantia Nigra of a Triple Transgenic Mouse Model of Alzheimer's Disease
Chenyou Sun et al.
CURRENT ALZHEIMER RESEARCH (2012)
Where, when, and in what form does sporadic Alzheimer's disease begin?
Heiko Braak et al.
CURRENT OPINION IN NEUROLOGY (2012)
Common factors among Alzheimer's disease, Parkinson's disease, and epilepsy: Possible role of the noradrenergic nervous system
Patricia Szot
EPILEPSIA (2012)
Norepinephrine differentially modulates the innate inflammatory response provoked by amyloid-β peptide via action at β-adrenoceptors and activation of cAMP/PKA pathway in human THP-1 macrophages
Ji Hye Yang et al.
EXPERIMENTAL NEUROLOGY (2012)
Roles of brain-derived neurotrophic factor/tropomyosin-related kinase B (BDNF/TrkB) signalling in Alzheimer's disease
Fang Zhang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2012)
The vincamine derivative vindeburnol provides benefit in a mouse model of multiple sclerosis: effects on the Locus coeruleus
Paul E. Polak et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Sendai virus vector-mediated brain-derived neurotrophic factor expression ameliorates memory deficits and synaptic degeneration in a transgenic mouse model of Alzheimer's disease
Yuki Iwasaki et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2012)
The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease
Sergey Kalinin et al.
NEUROBIOLOGY OF AGING (2012)
Locus coeruleus degeneration exacerbates olfactory deficits in APP/PS1 transgenic mice
Nolwen L. Rey et al.
NEUROBIOLOGY OF AGING (2012)
Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3xTgAD and nonTg mice
Chanpreet Singh et al.
NEUROBIOLOGY OF AGING (2012)
7,8-Dihydroxyflavone, a Small-Molecule TrkB Agonist, Reverses Memory Deficits and BACE1 Elevation in a Mouse Model of Alzheimer's Disease
Latha Devi et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Reduced Tissue Levels of Noradrenaline Are Associated with Behavioral Phenotypes of the TgCRND8 Mouse Model of Alzheimer's Disease
Beverly M. Francis et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Allopregnanolone Reinstates Tyrosine Hydroxylase Immunoreactive Neurons and Motor Performance in an MPTP-Lesioned Mouse Model of Parkinson's Disease
Samuel O. Adeosun et al.
PLOS ONE (2012)
Noradrenergic modulation of wakefulness/arousal
Craig W. Berridge et al.
SLEEP MEDICINE REVIEWS (2012)
Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis
Paul E. Polak et al.
BRAIN (2011)
The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE)
Travis Musgrave et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Regulation of CCL2/MCP-1 production in astrocytes by desipramine and atomoxetine: Involvement of α2 adrenergic receptors
Ara E. Hinojosa et al.
BRAIN RESEARCH BULLETIN (2011)
F,lix Vicq d'Azyr (1746-1794): early founder of neuroanatomy and royal French physician
R. Shane Tubbs et al.
CHILDS NERVOUS SYSTEM (2011)
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Heiko Braak et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Brain-Derived Neurotrophic Factor and Alzheimer's Disease: Physiopathology and Beyond
Breno Satler Diniz et al.
NEUROMOLECULAR MEDICINE (2011)
Chronic treatment with the α2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APP x PS1 transgenic mice without altering β-amyloid plaque load or astrocytosis
G. A. Scullion et al.
NEUROPHARMACOLOGY (2011)
DISTINCT ADRENERGIC SYSTEM CHANGES AND NEUROINFLAMMATION IN RESPONSE TO INDUCED LOCUS CERULEUS DEGENERATION IN APP/PS1 TRANSGENIC MICE
D. Jardanhazi-Kurutz et al.
NEUROSCIENCE (2011)
Neuronal vulnerability in Parkinson's disease
Kay L Double
PARKINSONISM & RELATED DISORDERS (2011)
Neuromelanin, neurotransmitter status and brainstem location determine the differential vulnerability of catecholaminergic neurons to mitochondrial DNA deletions
Matthias Elstner et al.
MOLECULAR BRAIN (2011)
Therapeutic utility of phosphodiesterase type I inhibitors in neurological conditions
Alexandre E. Medina
FRONTIERS IN NEUROSCIENCE (2011)
Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis
Ralf A. Linker et al.
BRAIN (2010)
Noradrenaline acting at central beta-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: Implications for neurodegeneration
Eoin N. McNamee et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
Noradrenaline induces IL-1ra and IL-1 type II receptor expression in primary glial cells and protects against IL-1β-induced neurotoxicity
Eoin N. McNamee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Norepinephrine and nitric oxide promote cell survival signaling in hippocampal neurons
Neha J. Patel et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Entacapone and Tolcapone, Two Catechol O-Methyltransferase Inhibitors, Block Fibril Formation of α-Synuclein and β-Amyloid and Protect against Amyloid-induced Toxicity
Saviana Di Giovanni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity
Scott E. Counts et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Increasing CNS Noradrenaline Reduces EAE Severity
Maria Vittoria Simonini et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2010)
Noradrenaline reuptake inhibitors inhibit expression of chemokines IP-10 and RANTES and cell adhesion molecules VCAM-1 and ICAM-1 in the CNS following a systemic inflammatory challenge
Joan B. O'Sullivan et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Norepinephrine enhances the LPS-induced expression of COX-2 and secretion of PGE2 in primary rat microglia
Johannes C. M. Schlachetzki et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Norepinephrine Promotes Microglia to Uptake and Degrade Amyloid β Peptide through Upregulation of Mouse Formyl Peptide Receptor 2 and Induction of Insulin-Degrading Enzyme
Yan Kong et al.
JOURNAL OF NEUROSCIENCE (2010)
The Effect of Peripheral Enzyme Inhibitors on Levodopa Concentrations in Blood and CSF
Maria Nord et al.
MOVEMENT DISORDERS (2010)
Induced LC degeneration in APP/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits
Daniel Jardanhazi-Kurutz et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease
D. Weintraub et al.
NEUROLOGY (2010)
Noradrenaline acting at β-adrenoceptors induces expression of IL-1β and its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex
Eoin N. McNamee et al.
NEUROPHARMACOLOGY (2010)
AGGRESSIVE BEHAVIOR DURING SOCIAL INTERACTION IN MICE IS CONTROLLED BY THE MODULATION OF TYROSINE HYDROXYLASE EXPRESSION IN THE PREFRONTAL CORTEX
K. Cambon et al.
NEUROSCIENCE (2010)
A COMPREHENSIVE ANALYSIS OF THE EFFECT OF DSP4 ON THE LOCUS COERULEUS NORADRENERGIC SYSTEM IN THE RAT
P. Szot et al.
NEUROSCIENCE (2010)
Gender effect on the accumulation of hyperphosphorylated tau in the brain of locus-ceruleus-injured APP-transgenic mouse
Naoto Oikawa et al.
NEUROSCIENCE LETTERS (2010)
Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine
Michael T. Heneka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Vinpocetine inhibits NF-κB-dependent inflammation via an IKK-dependent but PDE-independent mechanism
Kye-Im Jeon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Levodopa/carbidopa and entacapone in the treatment of Parkinson’s disease: efficacy, safety and patient preference
Thomas Müller
Patient Preference and Adherence (2010)
Atomoxetine Augmentation of Cholinesterase Inhibitor Therapy in Patients With Alzheimer Disease: 6-Month, Randomized, Double-Blind, Placebo-Controlled, Parallel-Trial Study
Richard C. Mohs et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2009)
Co-localization of hyperphosphorylated tau and caspases in the brainstem of Alzheimer's disease patients
Maria Sen Mun Wai et al.
BIOGERONTOLOGY (2009)
Autism, fever, epigenetics and the locus coeruleus
Mark F. Mehler et al.
BRAIN RESEARCH REVIEWS (2009)
The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokines
Patrick Vollmar et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)
Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration
Joan B. O'Sullivan et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)
Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis
Manolis Markianos et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Astrocyte-Derived MCP-1 Mediates Neuroprotective Effects of Noradrenaline
Jose L. M. Madrigal et al.
JOURNAL OF NEUROSCIENCE (2009)
Time-Dependent Activation of Phox2a by the Cyclic AMP Pathway Modulates Onset and Duration of p27Kip1 Transcription
Min Hwa Shin et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Early locus coeruleus degeneration and olfactory dysfunctions in Tg2576 mice
Delphine Guerin et al.
NEUROBIOLOGY OF AGING (2009)
The locus ceruleus norepinephrine system Functional organization and potential clinical significance
Eduardo E. Benarroch
NEUROLOGY (2009)
Age-dependent changes in noradrenergic locus coeruleus system in wild-type and APP23 transgenic mice
Patricia Szot et al.
NEUROSCIENCE LETTERS (2009)
Upregulation of Phagocyte-Derived Catecholamines Augments the Acute Inflammatory Response
Michael A. Flierl et al.
PLOS ONE (2009)
Restoration of Norepinephrine-Modulated Contextual Memory in a Mouse Model of Down Syndrome
A. Salehi et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
Functional consequences of locus coeruleus degeneration in Alzheimer's disease
David Weinshenker
CURRENT ALZHEIMER RESEARCH (2008)
Brainstem neuropathology in a mouse model of Niemann-Pick disease type C
Zhuo Luan et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Brain derived neurotrophic factor treatment reduces inflammation and apoptosis in experimental allergic encephalomyelitis
Tapas K. Makar et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Neuroprotective actions of noradrenaline: effects on glutathione synthesis and activation of peroxisome proliferator activated receptor delta
Jose L. M. Madrigal et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Catecholaminergic neuronal loss in locus coeruleus of aged female dtg APP/PS1 mice
Jahn N. O'Neil et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2007)
Increased catechol-O-methyltransferase activity and protein expression in OX-42-positive cells in the substantia nigra after lipopolysaccharide microinfusion
Teem Helkamaa et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice
K. S. Rommelfanger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Noradrenaline deficiency in brain increases β-amyloid plaque burden in an animal model of Alzheimer's disease
Sergey Kalinin et al.
NEUROBIOLOGY OF AGING (2007)
Orexin neuronal changes in the locus coeruleus of the aging rhesus macaque
Jodi L. Downs et al.
NEUROBIOLOGY OF AGING (2007)
Norepinephrine: The redheaded stepchild of 'Parkinson's disease'
K. S. Rommelfanger et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Reduced brain-derived neurotrophic factor is associated with a loss of serotonergic innervation in the hippocampus of aging mice
B. A. Luellen et al.
GENES BRAIN AND BEHAVIOR (2007)
Antidepressants inhibit interferon-γ-induced microglial production of IL-6 and nitric oxide
Sadayuki Hashioka et al.
EXPERIMENTAL NEUROLOGY (2007)
Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease
Aneta Grudzien et al.
NEUROBIOLOGY OF AGING (2007)
Repeated administration of the noradrenergic neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) modulates neuroinflammation and amyloid plaque load in mice bearing amyloid precursor protein and presenilin-I mutant transgenes
Perdita L. Pugh et al.
JOURNAL OF NEUROINFLAMMATION (2007)
Traumatic brain injury stimulates hippocampal catechol-O-methyl transferase expression in microglia
John B. Redell et al.
NEUROSCIENCE LETTERS (2007)
Polymorphisms of catechol-0-methyltransferase (COMT), monoamine oxidase B (MAOB), N-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson's disease
M. Bialecka et al.
PARKINSONISM & RELATED DISORDERS (2007)
Noradrenaline in Parkinson's disease: From disease progression to current therapeutics
Francesco Fornai et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations:: Potential factors in amyloid plaque formation
Holly Oakley et al.
JOURNAL OF NEUROSCIENCE (2006)
Effects of noradrenaline on neuronal NOS2 expression and viability
Jose L. M. Madrigal et al.
ANTIOXIDANTS & REDOX SIGNALING (2006)
Beta-amyloid-dependent expression of NOS2 in neurons:: Prevention by an α2-adrenergic antagonist
Sergey Kalinin et al.
ANTIOXIDANTS & REDOX SIGNALING (2006)
Genetic investigation of methylenetetrahydrofolate reductase (MTHFR) and catechol-O-methyl transferase (COMT) in multiple sclerosis
L Tajouri et al.
BRAIN RESEARCH BULLETIN (2006)
Effects of BDNF infusion on the axon terminals of locus coeruleus neurons of aging rats
S Nakai et al.
NEUROSCIENCE RESEARCH (2006)
Locus Ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice
MT Heneka et al.
JOURNAL OF NEUROSCIENCE (2006)
Transcriptional and translational regulation of BACE1 expression - Implications for Alzheimer's disease
Steffen Rossner et al.
PROGRESS IN NEUROBIOLOGY (2006)
The norepinephrine level is decreased in the lymphocytes of long-term interferon-beta-treated multiple sclerosis patients
C Rajda et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
The PDAPP mouse model of Alzheimer's disease: Locus coeruleus neuronal shrinkage
DC German et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2005)
Eburnamine derivatives and the brain
A Vas et al.
MEDICINAL RESEARCH REVIEWS (2005)
Age-associated changes in mRNA levels of Phox2, norepinephrine transporter and dopamine β-hydroxylase in the locus coeruleus and adrenal glands of rats
MY Zhu et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Activation of noradrenergic transmission by α2-adrenoceptor antagonists counteracts deafferentation-induced neuronal death and cell proliferation in the adult mouse olfactory bulb
A Veyrac et al.
EXPERIMENTAL NEUROLOGY (2005)
Norepinephrine protects cortical neurons against micro glial-induced cell death
JLM Madrigal et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Dehydroepiandrosterone sulfate and allopregnanolone directly stimulate catecholamine production via induction of tyrosine hydroxylase and secretion by affecting actin polymerization
I Charalampopoulos et al.
ENDOCRINOLOGY (2005)
Activation of catechol-O-methyltransferase in astrocytes stimulates homocysteine synthesis and export to neurons
GW Huang et al.
GLIA (2005)
The neurotransmitter noradrenaline rescues septal cholinergic neurons in culture from degeneration caused by low-level oxidative stress
S Traver et al.
MOLECULAR PHARMACOLOGY (2005)
Brain structures and receptors involved in alertness
G Aston-Jones
SLEEP MEDICINE (2005)
Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models
D Van Dam et al.
NEUROCHEMISTRY INTERNATIONAL (2005)
Noradrenergic mechanisms in neurodegenerative diseases: a theory
MR Marien et al.
BRAIN RESEARCH REVIEWS (2004)
BDNF is necessary for maintenance of noradrenergic innervations in the aged rat brain
W Matsunaga et al.
NEUROBIOLOGY OF AGING (2004)
β-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons
LQ Tong et al.
JOURNAL OF NEUROSCIENCE (2004)
Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis
M Gadea et al.
BRAIN (2004)
Dobutamine inhibits phorbol-myristate-acetate-induced activation of nuclear factor-κB in human T lymphocytes in vitro
T Loop et al.
ANESTHESIA AND ANALGESIA (2004)
Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors
JF Cryan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease
J Srinivasan et al.
BEHAVIOURAL BRAIN RESEARCH (2004)
Intrinsic regulation of brain inflammatory responses
E Galea et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2003)
Crucial role of TrkB ligands in the survival and phenotypic differentiation of developing locus coeruleus noradrenergic neurons
PC Holm et al.
DEVELOPMENT (2003)
MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis
EA Eugenin et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Noradrenergic depletion increases inflammatory responses in brain:: effects on IκB and HSP70 expression
MT Heneka et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases
C Zarow et al.
ARCHIVES OF NEUROLOGY (2003)
The toxicity of tumor necrosis factor-alpha upon cholinergic neurons within the nucleus basalis and the role of norepinephrine in the regulation of inflammation: Implications for Alzheimer's disease
GL Wenk et al.
NEUROSCIENCE (2003)
Treatment of multiple sclerosis with lofepramine, L-phenylalanine and vitamin B12:: mechanism of action and clinical importance:: roles of the locus coeruleus and central noradrenergic systems
C Loder et al.
MEDICAL HYPOTHESES (2002)
A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the Cari Loder regime) in the treatment of multiple sclerosis
DT Wade et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
Norepinephrine increases IκBα expression in astrocytes
V Gavrilyuk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Association of monoamine oxidase A gene polymorphism with Alzheimer's disease and Lewy body variant
M Takehashi et al.
NEUROSCIENCE LETTERS (2002)
Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimer's disease patients
L Emilsson et al.
NEUROSCIENCE LETTERS (2002)
Noradrenaline provides long-term protection to dopaminergic neurons by reducing oxidative stress
JD Troadec et al.
JOURNAL OF NEUROCHEMISTRY (2001)
MRI changes in multiple sclerosis following treatment with lofepramine and L-phenylalanine
BK Puri et al.
NEUROREPORT (2001)
A 27-bp region of the inducible nitric oxide synthase promoter regulates expression in glial cells
V Gavrilyuk et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Differential regulation of GDNF, neurturin, and their receptors in primary cultures of rat glial cells
S Rémy et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2001)
Age-dependent changes in noradrenergic innervations of the frontal cortex in F344 rats
Y Ishida et al.
NEUROBIOLOGY OF AGING (2001)
Neuroprotective activity of chemokines against N-methyl-D-aspartate or β-amyloid-induced toxicity in culture
V Bruno et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Singular subsets of locus coeruleus neurons may recover tyrosine hydroxylase phenotype transiently expressed during development
L Bezin et al.
MOLECULAR BRAIN RESEARCH (2000)
Preservation of midbrain catecholaminergic neurons in very old human subjects
N Kubis et al.
BRAIN (2000)
The association between vascular risk factor-mediating medications and cognition and dementia diagnosis in a community-based sample of African-Americans
SS Richards et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2000)
分享论文
